Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PROTAGENIC THERAPEUTICS, INC.

(PTIX)
 SummaryQuotesChartsNewsCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/18/2021 06/21/2021 06/22/2021 06/23/2021 06/24/2021 Date
2.94(c) 2.77(c) 2.77(c) 3.06(c) 3.11(c) Last
6 507 411 1 807 883 1 117 260 1 924 670 1 833 721 Volume
-12.76% -5.78% 0.00% +10.47% +1.63% Change
More quotes
Estimated financial data (e) (USD)
Sales 2019 - - -
Net income 2019 -1,75 M - -
Net cash position 2019 0,52 M - -
P/E ratio 2019 -8,26x
Yield 2019 -
Sales 2020 - - -
Net income 2020 -2,55 M - -
Net Debt 2020 0,70 M - -
P/E ratio 2020 -4,26x
Yield 2020 -
Capitalization 45,5 M 45,5 M -
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees -
Free-Float 76,6%
More Financials
Company
Protagenic Therapeutics, Inc., formerly Atrinsic, Inc., is a development-stage company. The Company is a biotechnology company that specializes in the discovery and development of therapeutics to treat central nervous system (CNS) disorders. The Company provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-base, brain active therapeutics. The Company has developed a... 
More about the company
All news about PROTAGENIC THERAPEUTICS, INC.
05/17PROTAGENIC THERAPEUTICS  : NEW Management's Discussion and Analysis of Financial..
AQ
05/05INSIDER TRENDS : Performance Technologies Insider Reports Option Conversion Exte..
MT
04/30PROTAGENIC THERAPEUTICS  : Announces Nasdaq Uplisting and
PU
04/30PROTAGENIC THERAPEUTICS, INC.NEW  : Entry into a Material Definitive Agreement, ..
AQ
04/21PROTAGENIC THERAPEUTICS, INC.NEW  : Regulation FD Disclosure, Financial Statemen..
AQ
04/08PROTAGENIC THERAPEUTICS, INC.NEW  : Regulation FD Disclosure, Financial Statemen..
AQ
03/25PROTAGENIC THERAPEUTICS  : NEW Management's Discussion and Analysis of Financial..
AQ
2020Dr. Maurizio Fava of Massachusetts General Hospital to Serve as Principal Inv..
GL
2020PROTAGENIC THERAPEUTICS  : NEW Management's Discussion and Analysis of Financial..
AQ
2020PROTAGENIC THERAPEUTICS, INC.NEW  : Submission of Matters to a Vote of Security ..
AQ
2020PROTAGENIC THERAPEUTICS  : Completes $2.0 Million Convertible Note Financing
AQ
2020Protagenic Therapeutics Completes $2.0 Million Convertible Note Financing
GL
2020PROTAGENIC THERAPEUTICS, INC.NEW  : Entry into a Material Definitive Agreement, ..
AQ
2020PROTAGENIC THERAPEUTICS  : NEW Management's Discussion and Analysis of Financial..
AQ
2020PROTAGENIC THERAPEUTICS, INC.NEW  : Change in Directors or Principal Officers (f..
AQ
More news
News in other languages on PROTAGENIC THERAPEUTICS, INC.

- No features available -

More news
Chart PROTAGENIC THERAPEUTICS, INC.
Duration : Period :
Protagenic Therapeutics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PROTAGENIC THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Managers and Directors
Alexander K. Arrow Chief Financial Officer
Garo H. Armen Executive Chairman
Robert Benjamin Stein Director & Chief Medical Officer
Andrew Slee Chief Operating Officer
Khalil Barrage Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
PROTAGENIC THERAPEUTICS, INC.0.00%46
MODERNA, INC.110.72%88 392
LONZA GROUP AG16.70%53 670
IQVIA HOLDINGS INC.34.45%46 441
CELLTRION, INC.-22.42%33 607
SEAGEN INC.-10.13%28 564